Lance C Pagliaro

Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer.

Kim-Anh Do, Sijin Wen, R. Millikan, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

Anthony Patterson, Mark K Buyyounouski, Khurshid A Guru, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.

Nancy J Cox, Robert D Frisina, M Eileen Dolan, 2014, Journal of the National Cancer Institute.

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.

Xin Wang, Fang Yang, Shouhao Zhou, 2019, JAMA oncology.

Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.

Stephen A Boorjian, J. Cheville, R. Thompson, 2017, European urology.

Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Anthony Patterson, Mark K Buyyounouski, Khurshid A Guru, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.